Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Zelda Therapeutics links up with International Cannabis and Cannabinoids Institute

Proactive Investors Monday, 11 February 2019
Zelda Therapeutics Ltd (ASX:ZLD) has engaged the International Cannabis and Cannabinoids Institute (ICCI) to support its clinical trial programs in autism, opioid reduction and insomnia.  This provides Zelda with an opportunity to collaborate with a panel of leading international medicinal cannabis experts. The ICCI is an international centre of excellence for the advancement of cannabis and cannabinoid treatments. The ICCI provides access to a global network of specialist services including expert advice on clinical study design and execution, requirements for regulatory approval, a full range of contract research services and direct liaison with study investigators. READ: Zelda Therapeutics on track to report on multiple clinical trials Zelda’s managing director Dr Richard Hopkins said “We’re honoured to be working with the ICCI and Dr Ethan Russo, who are recognised globally as leading authorities on medicinal cannabis. Their insights will help inform and accelerate our clinical trial programs. “Dr Russo and the ICCI will complement our existing medical advisory team and maintains Zelda’s strategy of engaging the world’s best medicinal cannabis researchers and clinicians.” Dr Ethan Russo was recently appointed the Director of Research and Development at the ICCI. He is a US-trained board-certified paediatric and adult neurologist, psychopharmacology researcher, former Senior Medical Advisor to GW Pharmaceuticals, and Medical Director of PHYTECS. Dr Russo said: “I’m delighted to be collaborating with Zelda who is at the forefront of efforts to develop plant-derived cannabis medicines that have the potential to improve quality of life for patients.” Progressing clinical and pre-clinical activities in 2019 Zelda remains on-track to report on the outcome from its clinical trials for insomnia, autism and opioid reduction by mid-2019. The company is also continuing to assess opportunities to expand its clinical programs where they align with its strategic objectives. Finally, Zelda is progressing discussions with third parties aiming at securing agreements to distribute clinically-validated Zelda products globally.
0
shares
ShareTweetSavePostSend
 
Credit: The Street - Published < > Embed
News video: Cannabis Will Cannibalize Beer, Says Jim Cramer

▶ Cannabis Will Cannibalize Beer, Says Jim Cramer 02:12

Don't be surprised about Constellation's investment in Canopy Growth , says Jim Cramer. Constellation Brands invested over $4 billion in cannabis company Canopy Growth. The investment also means that the two companies will be working closely together to produce cannabis-infused beverages. Back in...

You Might Like


Recent related videos from verified sources

Study: Daily cannabis use increases risk of psychotic disorder [Video]Study: Daily cannabis use increases risk of psychotic disorder

A newly-released study shows people who use cannabis every day are at higher risk of having a psychotic disorder.

Credit: KTNV Channel 13 Las Vegas     Duration: 00:23Published

It's Who Puts Money in Cannabis Companies That Matters: Jim Cramer [Video]It's Who Puts Money in Cannabis Companies That Matters: Jim Cramer

Jim Cramer says that, while Real Money Stock of the Day Aurora Cannabis bringing on Nelson Peltz as an adviser is the right move, typically it's who puts money into the cannabis company that matters. ..

Credit: The Street     Duration: 01:13Published

Aurora Is an 'Undervalued Company, Says Jim Cramer [Video]Aurora Is an 'Undervalued Company, Says Jim Cramer

Jim Cramer thinks that Aurora Cannabis is an undervalued company. He said that Real Money's Stock of the Day Aurora Cannabis's addition of Nelson Peltz as an adviser is a positive sign for the..

Credit: The Street     Duration: 00:53Published

Cannabis Is a Safe Haven If Economy Slows Down [Video]Cannabis Is a Safe Haven If Economy Slows Down

Cannabis stocks are all the rage, but a BMO Capital note downgrading Cronos Group based on valuation reiterates the importance of focusing on the fundamentals of individual companies. Paul Rosen,..

Credit: The Street     Duration: 05:50Published

Jim Cramer's Thoughts on U.S. and North Korea Summit and Palo Alto Networks [Video]Jim Cramer's Thoughts on U.S. and North Korea Summit and Palo Alto Networks

Happy hump day! Here are the headlines that Jim Cramer is looking at Wednesday. President Trump's Sit Down With Kim Jong Un President Trump sat down with North Korea's Kim Jong Un Wednesday morning in..

Credit: The Street     Duration: 18:52Published

Legend Of Zelda Remake For Switch May Come in Multiplayer [Video]Legend Of Zelda Remake For Switch May Come in Multiplayer

Legend Of Zelda Remake For Switch May Come in Multiplayer

Credit: Wochit Tech     Duration: 00:30Published

MedMen Is Already Praised as the 'Apple Store of Weed'—But Its Rapid Trajectory Is Getting Sticky [Video]MedMen Is Already Praised as the 'Apple Store of Weed'—But Its Rapid Trajectory Is Getting Sticky

Discussing your relationship with cannabis can be a dicey move—there’s still a stigma. If you bring it up around the wrong friend or co-worker or family member, you can instantly become a litany of..

Credit: Esquire     Duration: 03:21Published

Marijuana Earnings Reveal Troubling Trend in Canadian Cannabis [Video]Marijuana Earnings Reveal Troubling Trend in Canadian Cannabis

It's a big week in cannabis earnings ー Aurora Cannabis reported Monday and Canopy Growth will report Thursday ー but Paul Rosen, CEO of cannabis private equity firm Tidal Royalty, said he's noticing..

Credit: Cheddar Inc.     Duration: 01:48Published

Aurora Cannabis Is Squeezed By Higher Production Costs [Video]Aurora Cannabis Is Squeezed By Higher Production Costs

According to Business Insider, "Cannabis producer Aurora Cannabis beat on the top line. The company said its margins were lower as production costs jumped and prices fell." CEO Terry Booth in a press..

Credit: Wochit Business     Duration: 00:36Published

Harvard Study Finds That Cannabis Users Have A Higher Sperm Count [Video]Harvard Study Finds That Cannabis Users Have A Higher Sperm Count

According to a recent study, weed might boost sperm count. A new study out of Harvard showed cannabis users actually had higher sperm counts than non-users. These findings contradict scientists’..

Credit: NowThis News     Duration: 01:12Published


Recent related news from verified sources

ICC International Cannabis to sell CBD products across Europe under Marilyn Monroe and Elvis brand names

ICC International Cannabis Corp (CSE:WRLD.U) (OTCMKTS:WLDCF) is set to market and distribute its cannabidiol (CBD) health and wellness products across Europe...
Proactive Investors

Horizon Marijuana Life Sciences Index bolstered with new additions

A number of new cannabis players were added to the quarterly rebalance of the Horizon Marijuana Life Sciences Index (HMMJ) ETF on Monday. HMMJ bolstered its...
Proactive Investors

Buds & Duds: Harvest One acquires Delivra; ICC inks licensing agreement

The cannabis sector thrived Tuesday along with the broader US market.  The North American Marijuana Index, which tracks top cannabis stocks, grew 1% to 303.6....
Proactive Investors

Harvest One completes first shipment of medical cannabis to Shoppers Drug Mart

Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) announced Thursday that through its wholly-owned subsidiary and cultivation arm United Greeneries Ltd, it had...
Proactive Investors


Tweets about this


Other recent news in Business

ADIDAS: 10 per cent of our branded product in Asia are 'fakes'CITI FIRES EIGHT HONG KONG TRADERS AFTER REVIEW FINDS MISCONDUCT - sources
TRUMP REVERSES new sanctions on NKorea, bucking US TreasuryStocks Indexes Drop As Bond Market FLASHES RECESSION Warning
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.